Meari Taguchi

Meari Taguchi practices at Renown Regional Medical Center in Reno, Nevada, part of Renown Health.

Meari Taguchi's NPI, 1255838454, was assigned on April 12, 2018. Meari Taguchi holds Nevada license 24038.

Meari Taguchi's primary practice is Renown Regional Medical Center, at 1155 Mill Street, Reno, NV 89502 in Washoe County. The practice phone is (775) 982-4100.

Meari Taguchi's primary practice is Renown Regional Medical Center in Reno, Nevada, part of Renown Health. Meari Taguchi is also affiliated with Renown South Meadows Medical Center. The medical group on file is Renown Health. Dmand AI also links Meari Taguchi to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Meari Taguchi practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Meari Taguchi's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Meari Taguchi's licenses on file in 2 states: Nevada and Michigan.

CMS data shows 684 Medicare services from Meari Taguchi across 8 procedure codes in 2024, for 182 Medicare patients. Medicare paid $44,419 for them. Every service was in an office.

CMS counts 182 Medicare patients who saw Meari Taguchi in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Meari Taguchi's median patient age at 66, with 63% women.

In 2024, Meari Taguchi wrote 44 Medicare Part D claims for 12 patients. 100% of them were for generic drugs. CMS names the drug for 38 of them, across 2 drugs with 11 or more claims each, at $1,727 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

Meari Taguchi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Meari Taguchi as offering telehealth.

Dmand AI links 4 papers to Meari Taguchi, published from 2013 to 2022. 2022 was the busiest year, with 2. Meari Taguchi's most frequent co-authors are Anza Bilal Memon, MD, Poonam Bansal, MD and Kyle Bonner, MD.

CMS Open Payments shows 31 general payments to Meari Taguchi from 8 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $634.